Impact of fremanezumab treatment on disability outcomes in patients with migraine and major depressive disorder: Results of the UNITE study

被引：0

作者：

Mcallister, Peter ^{[1
]}

Campos, Verena Ramirez ^{[2
]}

Roth-Ben Arie, Zipora ^{[3
]}

Krasenbaum, Lynda ^{[4
]}

Ning, Xiaoping ^{[5
]}

Galic, Maja ^{[6
]}

Mitsikostas, Dimos ^{[7
]}

机构：

[1] New England Inst Neurol & Headache, Dept Neurol, Stamford, CT USA

[2] Teva Branded Pharmaceut Prod R&D Inc, Neurosci Headache & Movement Disorders, W Chester, PA USA

[3] Teva Pharmaceut Ind Ltd, Clin Operat, Petah Tiqwa, Israel

[4] Teva Branded Pharmaceut Prod R&D, Ta Migraine & Headache Global Med Affairs, W Chester, PA USA

[5] Teva Branded Pharmaceut Prod R&D, Cns Migraine Global Clin Dev, W Chester, PA USA

[6] TEVA PHARMA Prod Farmaceut Lda, Global Med Affairs, Porto Salvo, Portugal

[7] Natl & Kapodistrian Univ Athens, Dept Neurol 1, Athens, Greece

来源：

JOURNAL OF THE NEUROLOGICAL SCIENCES | 2023年 / 455卷

关键词：

D O I：

10.1016/j.jns.2023.121660

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

121660

引用

页数：2

共 50 条

[1] Impact of fremanezumab treatment on disability outcomes in patients with migraine and major depressive disorder: results of the UNITE study
McAllister, P.
Ramirez, Campos, V
Roth-Ben, Arie Z.
Krasenbaum, L.
Ning, X.
Galic, M.
Mitsikostas, D.
[J]. HEADACHE, 2023, 63 : 142 - 142
[2] UNITE: Efficacy and Impact of Fremanezumab in Patients with Migraine and Major Depressive Disorder
Campos, Verena Ramirez
Lipton, Richard B.
Krasenbaum, Lynda J.
Ning, Xiaoping
Barbanti, Piero
Roth-Ben Arie, Zipora
Galic, Maja
Denysenko, Lex
Marmura, Michael
McAllister, Peter
Mitsikostas, Dimos
[J]. CEPHALALGIA, 2023, 43 (1supp) : 64 - 65
[3] UNITE: Efficacy and impact of fremanezumab in patients with migraine and major depressive disorder
Ramirez Campos, V.
Lipton, R. B.
Krasenbaum, L. J.
Ning, X.
Barbanti, P.
Roth-Ben Arie, Z.
Galic, M.
Denysenko, L.
Marmura, M.
McAllister, P.
Mitsikostas, D. D.
[J]. JOURNAL OF HEADACHE AND PAIN, 2024, 25
[4] Efficacy of fremanezumab in reducing depression in patients with migraine and major depressive disorder: results of the UNITE study
Lipton, R.
Barbanti, P.
Campos, Ramirez, V
Arie, Roth-Ben Z.
Krasenbaum, L.
Ning, X.
Galic, M.
Denysenko, L.
[J]. HEADACHE, 2023, 63 : 133 - 134
[5] Efficacy of fremanezumab in reducing depression in patients with migraine and major depressive disorder: Results of the UNITE study
Lipton, Richard
Barbanti, Piero
Campos, Verena Ramirez
Roth-Ben Arie, Zipora
Krasenbaum, Lynda
Ning, Xiaoping
Galic, Maja
Denysenkoh, Lex
[J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
[6] Efficacy of fremanezumab treatment in reducing monthly migraine days in patients with migraine and major depressive disorder: Results from the UNITE study
Lipton, Richard
Campos, Verena Ramirez
Arie, Zipora Roth-Ben
Krasenbaum, Lynda
Ning, Xiaoping
Galic, Maja
Marmura, Michael
[J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
[7] Efficacy of fremanezumab treatment in reducing monthly migraine days in patients with migraine and major depressive disorder: results from the UNITE study
Lipton, R.
Campos, Ramirez, V
Roth-Ben, Arie Z.
Krasenbaum, L.
Ning, X.
Galic, M.
Marmura, M.
[J]. HEADACHE, 2023, 63 : 134 - 134
[8] A Phase 4 Study of Fremanezumab for Preventive Migraine Treatment in Patients With Major Depressive Disorder: Baseline Patient Characteristics in UNITE
Lipton, Richard B.
Campos, Verena Ramirez
Galic, Maja
Arie, Zipi Roth-Ben
Akcicek, Hasan
Lyras, Leonidas
Krasenbaum, Lynda J.
[J]. CEPHALALGIA, 2022, 42 (1_SUPPL) : 99 - 100
[9] The impact of migraine on patients with major depressive disorder
Hung, CI
Liu, CY
Juang, YY
Wang, SJ
[J]. HEADACHE, 2006, 46 (03): : 469 - 477
[10] The impact of anxiety and migraine on quality of sleep in patients with major depressive disorder
Hsu, Shih-Chieh
Wang, Shuu-Jiun
Liu, Chia-Yih
Juang, Yeong-Yuh
Yang, Ching-Hui
Hung, Ching-I
[J]. COMPREHENSIVE PSYCHIATRY, 2009, 50 (02) : 151 - 157

← 1 2 3 4 5 →